125 related articles for article (PubMed ID: 24789667)
1. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
[TBL] [Abstract][Full Text] [Related]
2. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
Bremner KE; Mitsakakis N; Wilson L; Krahn MD
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys.
Zamora V; Garin O; Pardo Y; Pont À; Gutiérrez C; Cabrera P; Gómez-Veiga F; Pijoan JI; Litwin MS; Ferrer M;
Value Health; 2021 Nov; 24(11):1676-1685. PubMed ID: 34711369
[TBL] [Abstract][Full Text] [Related]
4. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
[TBL] [Abstract][Full Text] [Related]
5. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
7. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.
Umbehr MH; Bachmann LM; Poyet C; Hammerer P; Steurer J; Puhan MA; Frei A
Health Qual Life Outcomes; 2018 Feb; 16(1):36. PubMed ID: 29458434
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
[TBL] [Abstract][Full Text] [Related]
9. Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26.
Zamora V; Garin O; Suárez JF; Jové J; Castells M; Ferrer F; Gutiérrez C; Guedea F; Boladeras A; Fumadó L; Roselló A; Pastor J; Samper P; Pont À; Ferrer M
World J Urol; 2023 Dec; 41(12):3511-3518. PubMed ID: 37947846
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC].
Ferrer M; Garin O; Pera J; Prats JM; Mendivil J; Alonso J; De Paula B; Herruzo I; Hervas A; Macias V; Mariño A; Ortiz MJ; Pastor S; Ponce De León J; Sancho G;
Med Clin (Barc); 2009 Feb; 132(4):128-35. PubMed ID: 19211071
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.
Marzorati C; Monzani D; Mazzocco K; Masiero M; Pavan F; Monturano M; Pravettoni G
Health Qual Life Outcomes; 2019 Aug; 17(1):147. PubMed ID: 31464649
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural adaptation and validation in spanish of the malocclusion impact questionnaire (MIQ).
Hope B; Zaror C; Sandoval P; Garay M; Streiner DL
Health Qual Life Outcomes; 2020 May; 18(1):146. PubMed ID: 32429932
[TBL] [Abstract][Full Text] [Related]
14. Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.
Schmidt S; Garin O; Pardo Y; Valderas JM; Alonso J; Rebollo P; Rajmil L; Garcia-Forero C; Ferrer M;
Qual Life Res; 2014 Oct; 23(8):2169-81. PubMed ID: 24748557
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
Szymanski KM; Wei JT; Dunn RL; Sanda MG
Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
[TBL] [Abstract][Full Text] [Related]
17. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
19. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).
Fosså SD; Storås AH; Steinsvik EA; Myklebust TA; Eri LM; Loge JH; Dahl AA
Scand J Urol; 2016 Aug; 50(4):280-5. PubMed ID: 27049891
[TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer.
Ritvo P; Irvine J; Naglie G; Tomlinson G; Bezjak A; Matthew A; Trachtenberg J; Krahn M
J Clin Epidemiol; 2005 May; 58(5):466-74. PubMed ID: 15845333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
